Similar articles

• [New aspects on systemic adverse effects of ocular drugs].

  Uusitalo H, Salminen L. Uusitalo H, et al. Duodecim. 1998;114(3):287-92. Duodecim. 1998. PMID: 10895504 Review. Finnish. No abstract available.
• [Glucocorticoids in ophthalmology- therapeutic value and strategies of rational utilization].

  Cârstocea B, Selaru D, Serban MM. Cârstocea B, et al. Oftalmologia. 2001;52(2):47-53. Oftalmologia. 2001. PMID: 11771102 Review. Romanian.
• Comparative study of two corticosteroid antimicrobial ophthalmic preparations.

  Breakey AS. Breakey AS. Eye Ear Nose Throat Mon. 1969 Nov;48(11):632-5. Eye Ear Nose Throat Mon. 1969. PMID: 5346002 Clinical Trial. No abstract available.
• Corticosteroids in the treatment of ocular histoplasmosis.

  Schlaegel TF Jr. Schlaegel TF Jr. Int Ophthalmol Clin. 1983 Summer;23(2):111-23. doi: 10.1097/00004397-198302320-00012. Int Ophthalmol Clin. 1983. PMID: 6853065 No abstract available.
• Ophthalmic use of glucocorticoids.

  Brightman AH 2nd. Brightman AH 2nd. Vet Clin North Am Small Anim Pract. 1982 Feb;12(1):33-9. doi: 10.1016/s0195-5616(82)50003-4. Vet Clin North Am Small Anim Pract. 1982. PMID: 7048713 Review. No abstract available.